25 October 2019

New Biotechnology publication validates Crescendo Biologics’ platform as it moves towards the clinic View PDF

16 October 2019

Crescendo Biologics presenting at key industry events during October 2019

View PDF

24 September 2019

Crescendo Biologics reaches fifth milestone in its strategic collaboration with Takeda View PDF

12 September 2019

Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey View PDF

05 September 2019

Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer View PDF 

23 July 2019

Crescendo Biologics’ second oncology-targeted Humabody^® licensed by Takeda View PDF 

24 June 2019

Crescendo Biologics to present preclinical data on its lead Humabody^® candidate, CB307, at the Cell Engager Therapeutics Summit 2019 View PDF

31 May 2019

Crescendo Biologics announces prestigious academic research collaborationsView PDF

29 May 2019

Crescendo Biologics achieves another milestone in its strategic collaboration with Takeda View PDF

02 May 2019

Crescendo awarded with EU patent on immunoglobulin libraries from transgenic animals View PDF

25 April 2019

Crescendo broadens patent protection in US on V_H-producing lambda chain KO mice View PDF

04 April 2019

Theodora Harold to be appointed new CEO at Crescendo Biologics View PDF

21 March 2019

Crescendo Biologics wins in “Life Science Innovation” category at the Business Weekly Awards 2019 View PDF

03 January 2019

Crescendo Biologics announces Humabody^® evaluation in CAR-T by Takeda View PDF